The roles of mutations in gyrA, parC, and ompK35 in fluoroquinolone resistance in Klebsiella pneumoniae

Microbial Drug Resistance

Volumn 9, Issue 3, 2003, Pages 265-271

  Chen, Feng Jui ^a   Lauderdale, Tsai Ling ^a   Ho, Monto ^a   Lo, Hsiu Jung ^a  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBONYL CYANIDE CHLOROPHENYLHYDRAZONE; CEFOTAXIME; CHLORAMPHENICOL; CIPROFLOXACIN; GENTAMICIN; KANAMYCIN; NALIDIXIC ACID; PORIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; CONTROLLED STUDY; DIFFUSION; EFFUSION; GYRA GENE; HOSPITAL; KLEBSIELLA PNEUMONIAE; NONHUMAN; NUCLEOTIDE SEQUENCE; OMPK35 GENE; OUTER MEMBRANE; PARC GENE; POINT MUTATION; PRIORITY JOURNAL; TAIWAN;

BACTERIA (MICROORGANISMS); KLEBSIELLA; KLEBSIELLA PNEUMONIAE;

EID: 0042355374     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/107662903322286472     Document Type: Article

References (37)

1. Aggeler, R., R.L. Then, and R. Ghosh. 1987. Reduced expression of outer-membrane proteins in beta-lactam-resistant mutants of Enterobacter cloacae. J. Gen. Microbiol. 133:3383-3392.
2. Alberti, S., F. Rodriquez-Quinones, T. Schirmer, G. Rummel, J.M. Tomas, J.P. Rosenbusch, and V.J. Benedi. 1995. A porin from Klebsiella pneumoniae: sequence homology, three-dimensional model, and complement binding. Infect. Immun. 63:903-910.
3. Ardanuy, C., J. Linares, M.A. Dominguez, S. Hernandez-Alles, V.J. Benedi, and L. Martinez-Martinez. 1998. Outer membrane profiles of clonally related Klebsiella pneumoniae isolates from clinical samples and activities of cephalosporins and carbapenems. Antimicrob. Agents Chemother. 42:1636-1640.
4. Belland, R.J., S.G. Morrison, C. Ison, and W.M. Huang. 1994. Neisseria gonorrhoeae acquires mutations in analogous regions of gyrA and parC in fluoroquinolone-resistant isolates. Mol. Microbiol. 14:371-380.
5. Chen, F.J., L.C. McDonald, M. Ho, and H.J. Lo. 2001. Identification of fluoroquinolone reduced-susceptibility in Escherichia coli: a herald for emerging resistance. J. Antimicrob. Chemother. 48:936-938.
6. Deguchi, T., A. Fukuoka, M. Yasuda, M. Nakano, S. Ozeki, E. Kanematsu, Y. Nishino, S. Ishihara, Y. Ban, and Y. Kawada. 1997. Alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in quinolone-resistant clinical isolates of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 41:699-701.
7. Deguchi, T., T. Kawamura, M. Yasuda, M. Nakano, H. Fukuda, H. Kato, N. Kato, Y. Okano, and Y. Kawada. 1997. In vivo selection of Klebsiella pneumoniae strains with enhanced quinolone resistance during fluoroquinolone treatment of urinary tract infections. Antimicrob. Agents Chemother. 41:1609-1611.
8. Dimri, G.P., and H.K. Das. 1990. Cloning and sequence analysis of gyrA gene of Klebsiella pneumoniae. Nucleic Acids Res. 18:151-156.
9. Domenech-Sanchez, A., S. Hernandez-Alles, L. Martinez-Martinez, V.J. Benedi, and S. Alberti. 1999. Identification and characterization of a new porin gene of Klebsiella pneumoniae: its role in beta-lactam antibiotic resistance. J Bacteriol. 181: 2726-2732.
10. Gruteke, P., W. Goessens, J. Van Gils, P. Peerbooms, N. Lemmens-Den Toom, M. Santen-Verheuvel, A. Van Belkum, and H. Verbrugh. 2003. Patterns of resistance associated with integrons, the extended-spectrum beta-lactamase SHV-5 gene, and a multidrug efflux pump of Klebsiella pneumoniae causing a nosocomial outbreak. J. Clin. Microbiol. 41:1161-1166.
11. Harder, K.J., H. Nikaido, and M. Matsuhashi. 1981. Mutants of Escherichia coli that are resistant to certain beta-lactam compounds lack the ompF porin. Antimicrob. Agents Chemother. 20:549-552.
12. Heisig, P. 1993. High-level fluoroquinolone resistance in a Salmonella typhimurium isolate due to alterations in both gyrA and gyrB genes. J. Antimicrob. Chemother. 32:367-377.
13. Heisig, P. 1996. Genetic evidence for a role of parC mutations in development of high-level fluoroquinolone resistance in Escherichia coli. Antimicrob. Agents Chemother. 40:879-885.
14. Heisig, P., H. Schedletzky, and H. Falkenstein-Paul. 1993. Mutations in the gyrA gene of a highly fluoroquinolone-resistant clinical isolate of Escherichia coli. Antimicrob. Agents Chemother. 37:696-701.
15. Hernandez-Alles, S., S. Alberti, D. Alvarez, A. Domenech-Sanchez, L. Martinez-Martinez, J. Gil, J.M. Tomas, and V.J. Benedi. 1999. Porin expression in clinical isolates of Klebsiella pneumoniae. Microbiology 145:673-679.
16. Hernandez-Alles, S., S. Alberti, X. Rubires, S. Merino, J.M. Tomas, and V.J. Benedi. 1995. Isolation of FC3-11, a bacteriophage specific for the Klebsiella pneumoniae porin OmpK36, and its use for the isolation of porin-deficient mutants. Can. J. Microbiol. 41:399-406.
17. Hernandez-Alles, S., V.J. Benedi, L. Martinez-Martinez, A. Pascual, A. Aguilar, J.M. Tomas, and S. Alberti. 1999. Development of resistance during antimicrobial therapy caused by insertion sequence interruption of porin genes. Antimicrob. Agents Chemother. 43:937-939.
18. Ho, M., L.C. McDonald, T.L. Lauderdale, L.L. Yeh, P.C. Chen, and Y.R. Shiau. 1999. Surveillance of antibiotic resistance in Taiwan, 1998. J. Microbiol. Immunol. Infect. 32:239-249.
19. Inokuchi, K., M. Itoh, and S. Mizushima. 1985. Domains involved in osmoregulation of the ompF gene in Escherichia coli. J. Bacteriol. 164:585-590.
20. Khodursky, A.B., E.L. Zechiedrich, and N.R. Cozzarelli. 1995. Topoisomerase IV is a target of quinolones in Escherichia coli. Proc. Natl. Acad. Sci. USA 92:11801-11805.
21. Kumagai, Y., J.I. Kato, K. Hoshino, T. Akasaka, K. Sato, and H. Ikeda. 1996. Quinolone-resistant mutants of Escherichia coli DNA topoisomerase IV parC gene. Antimicrob. Agents Chemother. 40:710-714.
22. Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
23. Martinez-Martinez, L., I. Garcia, S. Ballesta, V.J. Benedi, S. Hernandez-Alles, and A. Pascual. 1998. Energy-dependent accumulation of fluoroquinolones in quinolone-resistant Klebsiella pneumoniae strains. Antimicrob. Agents Chemother. 42:1850-1852.
24. Martinez-Martinez, L., S. Hernandez-Alles, S. Alberti, J.M. Tomas, V.J. Benedi, and G.A. Jacoby. 1996. In vivo selection of porin-deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expanded-spectrum-cephalosporins. Antimicrob. Agents Chemother. 40:342-348.
25. Mazzariol, A., J. Zuliani, G. Cornaglia, G.M. Rossolini, and R. Fontana. 2002. AcrAB efflux system: expression and contribution to fluoroquinolone resistance in Klebsiella spp. Antimicrob. Agents Chemother. 46:3984-3986.
26. McDonald, L.C., F.J. Chen, H.J. Lo, H.C. Yin, P.L. Lu, C.H. Huang, P. Chen, T.L. Lauderdale, and M. Ho. 2001. Emergence of reduced susceptibility and resistance to fluoroquinolones in Escherichia coli in Taiwan and contributions of distinct selective pressures. Antimicrob. Agents Chemother. 45:3084-3091.
27. Medeiros, A.A., T.F. O'Brien, E.Y. Rosenberg, and H. Nikaido. 1987. Loss of OmpC porin in a strain of Salmonella typhimurium causes increased resistance to cephalosporins during therapy. J. Infect. Dis. 156:751-757.
28. National Committee for Clinical Labortory Standards. 1999. Performance standards for antimicrobial susceptibility testing, ninth informational supplement. National Committee for Clinical Laboratory Standards. Wayne, PA.
29. Nikaido, H. 1989. Outer membrane barrier as a mechanism of antimicrobial resistance. Antimicrob. Agents Chemother. 33: 1831-1836.
30. Paterson, D.L., L. Mulazimoglu, J.M. Casellas, W.C. Ko, H. Goossens, A. Von Gottberg, S. Mohapatra, G.M. Trenholme, K.P. Klugman, J.G. McCormack, and V.L. Yu. 2000. Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia. Clin. Infect. Dis. 30:473-478.
31. Piddock, L.J. 1999. Mechanisms of fluoroquinolone resistance: an update 1994-1998. Drugs 58(Suppl1):11-18.
32. Poole, K. 2000. Efflux-mediated resistance to fluoroquinolones in gram-negative bacteria. Antimicrob. Agents Chemother. 44: 2233-2241.
33. Vasallo, F.J., P. Martin-Rabadan, L. Alcala, J.M. Garcia-Lechuz, M. Rodriguez-Creixems, and E. Bouza. 1998. Failure of ciprofloxacin therapy for invasive nontyphoidal salmonellosis [letter; comment]. Clin. Infect. Dis. 26:535-536.
34. von Rosenstiel, N., and D. Adam. 1994. Quinolone antibacterials. An update of their pharmacology and therapeutic use. Drugs 47:872-901.
35. Weigel, L.M., C.D. Steward, and F.C. Tenover. 1998. gyrA mutations associated with fluoroquinolone resistance in eight species of Enterobacteriaceae. Antimicrob. Agents Chemother. 42:2661-2667.
36. Yoshida, H., M. Bogaki, M. Nakamura, and S. Nakamura. 1990. Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli. Antimicrob. Agents Chemother. 34:1271-1272.
37. Yoshida, H., M. Nakamura, M. Bogaki, H. Ito, T. Kojima, H. Hattori, and S. Nakamura. 1993. Mechanism of action of quinolones against Escherichia coli DNA gyrase. Antimicrob. Agents Chemother. 37:839-845.